Literature DB >> 15889129

Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis.

S Kõks1, K Kingo, K Vabrit, R Rätsep, M Karelson, H Silm, E Vasar.   

Abstract

The aim of present study was to elucidate the role of the interleukin (IL)-24 gene in predicting risk for plaque-type psoriasis and to describe the linkage disequilibrium (LD) pattern emerging from the genes of IL-19, IL-20 and IL-24. Genes encoding IL-19, IL-20 and IL-24 locate in the region q32 of chromosome 1. The association between the single-nucleotide polymorphisms (SNPs) or haplotypes of the IL-24 gene and the susceptibility of psoriasis was not found. However, a significant protective effect of the combined haplotype CAAAC of IL-20 and IL-24 genes against plaque-type psoriasis was established (OR 0.154). Protective effect against psoriasis was also observed with haplotype TGGGT (OR 0.591) and haplotype CGAGT (OR 0.457). Performing a comprehensive analysis using the data regarding SNPs of IL-24 gene together with the previously published data regarding IL-19 and IL-20 SNPs, we identified two haplotype blocks within the region q32 of chromosome 1. The main result of the present study is that while the IL-19/IL-20 extended haplotype CACCGGAA is a significant susceptibility factor for psoriasis (previous study), IL-20/IL-24 haplotypes CAAAC, TGGGT and CGAGT have a significant protective effect. Nevertheless, family-based studies are required to confirm the impact of IL-19, IL-20 and IL-24 genes in the genetic predisposition for psoriasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889129     DOI: 10.1038/sj.gene.6364216

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  16 in total

1.  Interleukin-19 in fetal systemic inflammation.

Authors:  Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Roberto Romero; Youssef Hussein; Juan Pedro Kusanovic; Yi Xu; Zhong Dong; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-03

2.  IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.

Authors:  Ellen Witte; Georgios Kokolakis; Katrin Witte; Sandra Philipp; Wolf-Dietrich Doecke; Nina Babel; Bianca M Wittig; Katarzyna Warszawska; Agata Kurek; Magdalena Erdmann-Keding; Stefanie Kunz; Khusru Asadullah; Marshall E Kadin; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk; Robert Sabat
Journal:  J Invest Dermatol       Date:  2014-07-21       Impact factor: 8.551

Review 3.  The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Authors:  Marina Talamonti; Simone D'Adamio; Luca Bianchi; Marco Galluzzo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

4.  Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation.

Authors:  R Scrivo; P Conigliaro; V Riccieri; M Di Franco; C Alessandri; A Spadaro; R Perricone; G Valesini
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

5.  Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma.

Authors:  Fei Huang; Shinichiro Wachi; Philip Thai; Artem Loukoianov; Kin Hup Tan; Rosanna Malbran Forteza; Reen Wu
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

6.  Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.

Authors:  Ann L Truelove; Taras K Oleksyk; Sadeep Shrestha; Chloe L Thio; James J Goedert; Sharyne M Donfield; Gregory D Kirk; David L Thomas; Stephen J O'Brien; Michael W Smith
Journal:  Int J Immunogenet       Date:  2008-06       Impact factor: 1.466

7.  Potential synergy between SNP and CpG-A or IL-1β in regulating transcriptional activity of IL-20 promoter.

Authors:  Lanqi Wang; Kejia Li; Qiannan Xu; Xiaoying Chen; Feng Xue; Ruofei Shi; Jie Zheng
Journal:  J Invest Dermatol       Date:  2013-07-26       Impact factor: 8.551

8.  Interleukin-19: a constituent of the regulome that controls antigen presenting cells in the lungs and airway responses to microbial products.

Authors:  Carol Hoffman; Sung-Hyun Park; Eleen Daley; Claire Emson; Jennifer Louten; Maureen Sisco; Rene de Waal Malefyt; Gabriele Grunig
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

9.  Novel IL10 gene family associations with systemic juvenile idiopathic arthritis.

Authors:  Mark S Fife; Ana Gutierrez; Emma M Ogilvie; Carmel J W Stock; Jane M Samuel; Wendy Thomson; Lisa F Mack; Cathryn M Lewis; Patricia Woo
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.

Authors:  Tanel Traks; Kati Koido; Triin Eller; Eduard Maron; Külli Kingo; Veiko Vasar; Eero Vasar; Sulev Kõks
Journal:  BMC Med Genet       Date:  2008-12-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.